TEL AVIV, Israel (AP) — TEL AVIV, Israel (AP) — Galmed Pharmaceuticals Ltd. (GLMD) on Wednesday reported a loss of $1.6 million in its second quarter.
The Tel Aviv, Israel-based company said it had a loss of 95 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLMD at https://www.zacks.com/ap/GLMD
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
Nancy Pelosi's husband Paul Pelosi uses an investing strategy that lowers upfront costs.
Whether or not these stocks hit analysts' price targets, they all should be attractive to investors seeking great income and solid growth.
This leading semiconductor company could turbocharge your returns.
Here's what could happen next to Alphabet shares.
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
The $50 million purchase could turn into Nvidia's biggest investment.
I’m 58 and I have $700,000 in 401(k)s and IRAs. I have no credit card debt, no auto loan payments and no student loans. I sold my home in California and paid cash for a house in Texas, so I have no mortgage. I’m retired military and bring in about $2,200 per month after taxes. […] The post Ask an Advisor: How Do I Cover $3,000 in Monthly Living Expenses? I’m 58 With $700k in Retirement Savings, But I Won’t Collect Social Security for 7 Years appeared first on SmartReads by SmartAsset.
The number probably isn't anywhere near what you think it is.